| Human Epidermal Growth Factor Receptor 2 Pan Tumor Indication for Trastuzumab Deruxtecan JT Jørgensen, K Egebjerg, AV Lænkholm, M Mau-Sørensen Journal of Clinical Oncology, JCO. 24.00884, 2024 | | 2024 |
| Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors N Steeghs, C Gomez-Roca, KS Rohrberg, M Mau-Sørensen, D Robbrecht, ... Clinical Cancer Research, OF1-OF9, 2024 | | 2024 |
| Comprehensive analysis of failure to carry out successful genomic profiling in a phase I setting L Belcaid, C Iden, I Jacobsen, M Højgaard, I Spanggaard, IV Tuxen, ... ESMO open 9 (6), 2024 | | 2024 |
| Phase 3 dose selection for selinexor in TP53wt endometrial cancer based on exposure-response analysis. V Makker, DL Richardson, HS Chon, DS Miller, M Mau-Sørensen, ... Journal of Clinical Oncology 42 (16_suppl), 5594-5594, 2024 | | 2024 |
| DNA methylation markers for sensitive detection of circulating tumor DNA in patients with gastroesophageal cancers N Ogaard, CR Iden, S Ostrup Jensen, SM Mustafa, E Aagard, JB Bramsen, ... medRxiv, 2024.03. 04.24303699, 2024 | | 2024 |
| Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan M Mau-Sørensen, J Gerner-Rasmussen, O Hansen, B Holm, CH Nyhus, ... Acta Oncologica 62 (12), 1979-1982, 2023 | | 2023 |
| Abstract C050: Comprehensive analysis of causes for unsuccessful genomic profiling in a Phase 1 setting C Iden, L Belcaid, I Jacobsen, M Hoejgaard, I Spanggaard, ... Molecular Cancer Therapeutics 22 (12_Supplement), C050-C050, 2023 | | 2023 |
| Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer RL Eefsen, JS Larsen, LL Klarskov, R Altaf, E Høgdall, P Ingeholm, ... International Journal of Cancer 152 (10), 2145-2152, 2023 | 8 | 2023 |
| Harms of exercise training in patients with cancer undergoing systemic treatment: a systematic review and meta-analysis of published and unpublished controlled trials SN Thomsen, IM Lahart, LM Thomsen, MK Fridh, A Larsen, ... EClinicalMedicine 59, 2023 | 16 | 2023 |
| DNA methylation markers for sensitive detection of circulating tumor DNA in plasma from patients with gastroesophageal adenocarcinomas CR Iden, N Øgaard, SØ Jensen, SM Mustafa, LB Ahlborn, JP Hasselby, ... Cancer Research 83 (7_Supplement), 2290-2290, 2023 | | 2023 |
| Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy A Borch, AM Bjerregaard, V Araujo Barbosa de Lima, O Østrup, CW Yde, ... Frontiers in genetics 14, 1058605, 2023 | 2 | 2023 |
| Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET‐dysregulated solid tumours X Chen, N Isambert, R López‐López, M Giovannini, N Pognan, S Kapoor, ... British Journal of Clinical Pharmacology 89 (3), 1046-1055, 2023 | | 2023 |
| Harms of exercise training in patients with cancer undergoing systemic treatment: a protocol for a systematic review and meta-analysis of published and unpublished controlled … SN Thomsen, IM Lahart, LM Thomsen, MK Fridh, A Larsen, ... OSF, 2023 | 1 | 2023 |
| P-238 Pattern of failure after radiotherapy for squamous cell carcinoma of the anus K Wind, C Kronborg, A Jakobsen, M Sørensen, K Spindler Annals of Oncology 33, S333, 2022 | | 2022 |
| First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours D Robbrecht, C Jungels, MM Sorensen, I Spanggaard, F Eskens, ... British Journal of Cancer 126 (7), 1010-1017, 2022 | 13 | 2022 |
| Patients in phase 1 cancer trials: psychological distress and understanding of trial information KT Gad, U Lassen, AK Duun-Henriksen, SO Dalton, M Mau-Sørensen, ... Acta Oncologica 61 (3), 341-348, 2022 | 1 | 2022 |
| A phase II study of the efficacy and safety of oral selinexor in recurrent glioblastoma AB Lassman, PY Wen, MJ van den Bent, SR Plotkin, AME Walenkamp, ... Clinical Cancer Research 28 (3), 452-460, 2022 | 49 | 2022 |
| Cirkulerende tumor-DNA ved behandling af kræft CR Iden, AFB Johansen, N Øgaard, IB Kongsfelt, K Egebjerg, ... Ugeskrift for Læger 183 (2), V02210154, 2022 | | 2022 |
| Perioperative exercise training for patients with gastrointestinal cancer undergoing surgery: A systematic review and meta-analysis SN Thomsen, ST Mørup, M Mau-Sørensen, M Sillesen, I Lahart, ... European Journal of Surgical Oncology 47 (12), 3028-3039, 2021 | 6 | 2021 |
| Circulating tumour DNA in the treatment of cancer CR Iden, AFB Johansen, N Øgaard, IB Kongsfelt, K Egebjerg, ... Ugeskrift for Laeger 183 (32), V02210154-V02210154, 2021 | | 2021 |
Ulrik Lassen, Professor, MD, PH.D.Phase 1 Unit, Department of OncologyVerified email at regionh.dk
